The team also synthesized AuNPs functionalized with a bio-inspired fusion protein carrier to target human epidermal growth factor receptor-2 (HER2) for ovarian cancer and simultaneously co-deliver doxorubicin and siRNA against erbB2. The gene discussed is ERBB2; the disease is ovarian carcinoma.